Points taken, but how quickly could this trial go with an active pool of trial patients? It seems like this could go pretty quickly and might provide a little more upside to potential suitors. The target (yellow fever now third focus) seems to have changed since last update which intrigues me.

Probably all wet on this, so please correct my hoptimism.